At a glance
ClinicalIndex Comparison RecordN/ACompleted· 93 enrolled
Drug / intervention
Lab A1C +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Demonstration Study of the Interest of the MEDTRUM A7+ TouchCare Insulin Patch Pump Versus INSULET Omnipod® Patch Pump
In Brief
A clinical study evaluating Medtrum A7+ insulin Pump and Lab A1C for Diabetes Mellitus. Completed, enrolled 93 participants across 1 site.
Detailed Summary
Demonstration study of the interest of the MEDTRUM A7+ TouchCare insulin patch pump versus INSULET Omnipod® patch pump
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartJan 2020
Primary CompletionMar 2021
Study CompletionJun 2021
TodayJul 2026
First PostedJan 13, 2020
Enrollment StartJan 29, 2020
Primary CompletionMar 1, 2021
Study CompletionJun 1, 2021
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.5 years ago
Interventions
Medtrum A7+ insulin Pumpdevice
Use of the Medtrum pump during 3 months in combination with a CGM (Continuous Glucose Measurement)
Lab A1Cbiological
Measure of Lab A1C at baseline and end of study